{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06030648",
            "orgStudyIdInfo": {
                "id": "2022LS001"
            },
            "organization": {
                "fullName": "Masonic Cancer Center, University of Minnesota",
                "class": "OTHER"
            },
            "briefTitle": "MT2022-01: MSCs for ALD",
            "officialTitle": "Intravenous Administration of Mesenchymal Stem Cells (IV-MSC) for the Treatment of Cerebral Adrenoleukodystrophy (cALD)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "mscs-for-ald"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-09",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-08-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-05-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-08-31",
            "studyFirstSubmitQcDate": "2023-09-07",
            "studyFirstPostDateStruct": {
                "date": "2023-09-11",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-09-07",
            "lastUpdatePostDateStruct": {
                "date": "2023-09-11",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Masonic Cancer Center, University of Minnesota",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a single-institution study to evaluate the use of intravenously administered allogeneic, 3rd party mesenchymal stem cells (IV-MSC) in patients with active, cerebral adrenoleukodystrophy (CALD), as a bridge to hematopoietic stem cell transplant or gene therapy, or in patients who are too advanced for gene therapy or HSCT. The intervention will occur in the time between diagnosis of active CALD and transplant which is currently 8-12 weeks."
        },
        "conditionsModule": {
            "conditions": [
                "Cerebral Adrenoleukodystrophy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 10,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "IV-MSC for cALD (Early Disease/Bridge Therapy)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with active, cerebral adrenoleukodystrophy (cALD) as a bridge to hematopoietic stem cell transplant or gene therapy.",
                    "interventionNames": [
                        "Biological: Mesenchymal stem cells (IV-MSC)"
                    ]
                },
                {
                    "label": "IV-MSC for cALD (Advanced Disease)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with active, cerebral adrenoleukodystrophy (cALD) who are too advanced for gene therapy or HSCT.",
                    "interventionNames": [
                        "Biological: Mesenchymal stem cells (IV-MSC)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "Mesenchymal stem cells (IV-MSC)",
                    "description": "Patients will receive 1 infusion (1 x 106 cells/kg on day 0) then be followed for 8 weeks from the infusion.",
                    "armGroupLabels": [
                        "IV-MSC for cALD (Advanced Disease)",
                        "IV-MSC for cALD (Early Disease/Bridge Therapy)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Safety and tolerability of intravenously-administered allogeneic, third-party mesenchymal stem cells (IV-MSC).",
                    "description": "Safety and tolerability of cerebral adrenoleukodystrophy (cALD) patients receiving intravenously-administered allogeneic, third-party mesenchymal stem cells (IV-MSC) assessed by incidence of adverse events.",
                    "timeFrame": "6 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Incidence of radiographic response in patients receiving intravenously-administered allogeneic, third-party mesenchymal stem cells (IV-MSC).",
                    "description": "Radiographic response is defined as the resolution of intravenous gadolinium contrast enhancement on brain MRI.",
                    "timeFrame": "6 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* age \u2265 3 years\n* diagnosis of ALD, as established by elevation of very long chain fatty acid levels or gene mutation\n* evidence of active cerebral disease as determined by the presence of gadolinium enhancement\n* ALD MRI (Loes) score \u2265 1\n* Patients who have not received prior gene therapy or transplant\n* Life expectancy of \\> 6 months as determined by the enrolling researcher\n* Have adequate organ function confirmed by laboratory values obtained within 28 days prior to enrollment\n\nExclusion Criteria:\n\n* Inability to undergo sedation or MRI studies for any reason\n* Other concurrent life-threatening disease (life expectancy \\<6 months) or eligible for hospice care\n* Known or suspected hypersensitivity to human serum albumin, diphenhydramine, acetaminophen, methylprednisolone, or any of the components of IMS001.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "3 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Troy C Lund, MD",
                    "role": "CONTACT",
                    "phone": "+1 612-626-2778",
                    "email": "lundx072@umn.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Masonic Cancer Center, University of Minnesota",
                    "status": "RECRUITING",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55455",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Troy C Lund, MD",
                            "role": "CONTACT",
                            "phone": "612-626-2778",
                            "email": "lundx072@umn.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000326",
                    "term": "Adrenoleukodystrophy"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020739",
                    "term": "Brain Diseases, Metabolic, Inborn"
                },
                {
                    "id": "D000001928",
                    "term": "Brain Diseases, Metabolic"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000020279",
                    "term": "Hereditary Central Nervous System Demyelinating Diseases"
                },
                {
                    "id": "D000056784",
                    "term": "Leukoencephalopathies"
                },
                {
                    "id": "D000003711",
                    "term": "Demyelinating Diseases"
                },
                {
                    "id": "D000038901",
                    "term": "Mental Retardation, X-Linked"
                },
                {
                    "id": "D000008607",
                    "term": "Intellectual Disability"
                },
                {
                    "id": "D000019954",
                    "term": "Neurobehavioral Manifestations"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000040181",
                    "term": "Genetic Diseases, X-Linked"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000020271",
                    "term": "Heredodegenerative Disorders, Nervous System"
                },
                {
                    "id": "D000008661",
                    "term": "Metabolism, Inborn Errors"
                },
                {
                    "id": "D000018901",
                    "term": "Peroxisomal Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000000309",
                    "term": "Adrenal Insufficiency"
                },
                {
                    "id": "D000000307",
                    "term": "Adrenal Gland Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3677",
                    "name": "Adrenoleukodystrophy",
                    "asFound": "Adrenoleukodystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5205",
                    "name": "Brain Diseases, Metabolic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22498",
                    "name": "Brain Diseases, Metabolic, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6909",
                    "name": "Demyelinating Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22099",
                    "name": "Hereditary Central Nervous System Demyelinating Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M28591",
                    "name": "Leukoencephalopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M11589",
                    "name": "Intellectual Disability",
                    "relevance": "LOW"
                },
                {
                    "id": "M24774",
                    "name": "Mental Retardation, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "M21826",
                    "name": "Neurobehavioral Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M24877",
                    "name": "Genetic Diseases, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M22092",
                    "name": "Heredodegenerative Disorders, Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M11641",
                    "name": "Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20939",
                    "name": "Peroxisomal Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M3661",
                    "name": "Adrenal Insufficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "M3659",
                    "name": "Adrenal Gland Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T218",
                    "name": "Adrenomyeloneuropathy",
                    "asFound": "Adrenoleukodystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5954",
                    "name": "X-linked Adrenoleukodystrophy",
                    "asFound": "Adrenoleukodystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4503",
                    "name": "Peroxisomal Biogenesis Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}